UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARAA
5676
DELISTED
Paramount Global Class A
PARAA
| $621K | ﹤0.01% |
27,846
+21,782
| +359% | +$486K |
|
|
BHR
5677
Braemar Hotels & Resorts
BHR
$142M
| $621K | ﹤0.01% |
206,988
-23,002
| -10% | -$74.5K |
|
5678
PUT
eBay
EBAY
$49.8B
| $620K | ﹤0.01% |
10,000
| – | – |
|
5679
Direxion Daily Retail Bull 3X ETF
RETL
$29.2M
| $619K | ﹤0.01% |
62,688
+58,450
| +1,379% | +$576K |
|
5680
Aligos Therapeutics
ALGS
$34.9M
| $618K | ﹤0.01% |
15,521
+15,507
| +110,764% | +$300K |
|
5681
CALL
Vulcan Materials
VMC
$36.9B
| $617K | ﹤0.01% |
+2,400
| New | +$645K |
|
|
5682
PUT
Vulcan Materials
VMC
$36.9B
| $617K | ﹤0.01% |
+2,400
| New | +$645K |
|
5683
Perma-Fix Environmental Services
PESI
$383M
| $616K | ﹤0.01% |
55,686
+48,859
| +716% | +$643K |
|
5684
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$495M
| $616K | ﹤0.01% |
12,146
-3,081
| -20% | -$161K |
|
5685
Granite Ridge Resources
GRNT
$644M
| $616K | ﹤0.01% |
95,302
+40,045
| +72% | +$248K |
|
5686
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$395M
| $615K | ﹤0.01% |
11,846
-138
| -1% | -$7.49K |
|
5687
BayCom
BCML
$333M
| $614K | ﹤0.01% |
22,859
+8,833
| +63% | +$233K |
|
5688
Global X MSCI China Consumer Discretionary ETF
CHIQ
$125M
| $611K | ﹤0.01% |
32,207
-12,404
| -28% | -$255K |
|
5689
Foster
FSTR
$432M
| $608K | ﹤0.01% |
22,607
+11,046
| +96% | +$264K |
|
|
GDO
5690
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
| $607K | ﹤0.01% |
53,573
-5,504
| -9% | -$65.2K |
|
|
QVMT
5691
Invesco S&P 500 Concentrated QVM ETF
QVMT
$134M
| $606K | ﹤0.01% |
12,314
+630
| +5% | +$32.2K |
|
5692
Oric Pharmaceuticals
ORIC
$1.4B
| $605K | ﹤0.01% |
74,929
+3,374
| +5% | +$31K |
|
5693
CS Disco
LAW
$279M
| $605K | ﹤0.01% |
121,168
-8,956
| -7% | -$52K |
|
5694
CALL
CME Group
CME
$94.8B
| $604K | ﹤0.01% |
2,600
-19,900
| -88% | -$4.58M |
|
5695
Mineralys Therapeutics
MLYS
$2.41B
| $602K | ﹤0.01% |
48,885
+32,785
| +204% | +$429K |
|
5696
Consensus Cloud Solutions
CCSI
$647M
| $602K | ﹤0.01% |
25,216
+17,004
| +207% | +$399K |
|
|
BIOA
5697
BioAge Labs
BIOA
$538M
| $602K | ﹤0.01% |
+103,891
| New | +$1.79M |
|
5698
Domo
DOMO
$184M
| $601K | ﹤0.01% |
84,855
+65,365
| +335% | +$529K |
|
5699
Business First Bancshares
BFST
$1.03B
| $601K | ﹤0.01% |
23,375
+6,570
| +39% | +$176K |
|
5700
Peapack-Gladstone Financial
PGC
$812M
| $599K | ﹤0.01% |
18,701
+2,007
| +12% | +$66.5K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.